LA JOLLA (Germany) Today

Equity ratings for LA JOLLA PHARM are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of August 2020 and ending today, the 3rd of August 2021. Click here to learn more.
LA JOLLA PHARM cannot be verified against its exchange. Apparently, LA JOLLA is not available for investing at the moment. Please verify the symbol is currently traded on Frankfurt Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

LA JOLLA Stock Profile

La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company was founded in 1989 and is headquartered in San Diego, California. LA JOLLA operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 169 people.. The public information regarding LA JOLLA PHARM's current market price is not available at this time.
LA JOLLA PHARM is not yet fully synchronised with the market data
LA JOLLA PHARM has some characteristics of a very speculative penny stock
LA JOLLA PHARM has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 17.75 M. Net Loss for the year was (158.26 M) with loss before overhead, payroll, taxes, and interest of (106.49 M).
LA JOLLA PHARM has accumulated about 123.45 M in cash with (118.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.55.
Legal NameLA JOLLA PHARM
CEOGeorge Tidmarsh  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of LA JOLLA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
LA JOLLA PHARM (LJPP) is traded on Frankfurt Stock Exchange in Germany and employs 169 people. The company currently falls under 'Small-Cap' category with current market capitalization of 222.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate LA JOLLA's market, we take the total number of its shares issued and multiply it by LA JOLLA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. LA JOLLA PHARM operates under Healthcare sector and is part of Biotechnology industry. The entity has 27.08 M outstanding shares. LA JOLLA PHARM has accumulated about 123.45 M in cash with (118.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.55.
Check LA JOLLA Probability Of Bankruptcy

LA JOLLA Stock Against Markets

Picking the right benchmark for LA JOLLA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in LA JOLLA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for LA JOLLA is critical whether you are bullish or bearish towards LA JOLLA PHARM at a given time.
LA JOLLA PHARM cannot be verified against its exchange. Apparently, LA JOLLA is not available for investing at the moment. Please verify the symbol is currently traded on Frankfurt Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LA JOLLA stock to make a market-neutral strategy. Peer analysis of LA JOLLA could also be used in its relative valuation, which is a method of valuing LA JOLLA by comparing valuation metrics with similar companies.

LA JOLLA Corporate Executives

Elected by the shareholders, the LA JOLLA's board of directors comprises two types of representatives: LA JOLLA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LA JOLLA. The board's role is to monitor LA JOLLA's management team and ensure that shareholders' interests are well served. LA JOLLA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LA JOLLA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Check out Stocks Correlation. Note that the LA JOLLA PHARM information on this page should be used as a complementary analysis to other LA JOLLA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Tools for LA JOLLA Stock

When running LA JOLLA PHARM price analysis, check to measure LA JOLLA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LA JOLLA is operating at the current time. Most of LA JOLLA's value examination focuses on studying past and present price action to predict the probability of LA JOLLA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move LA JOLLA's price. Additionally, you may evaluate how the addition of LA JOLLA to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go